-
Product Insights
Systemic Lupus Erythematosus - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Systemic Lupus Erythematosus - Global Clinical Trials Review, 2026" provides an overview of Systemic Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Systemic Lupus Erythematosus and Lupus Nephritis Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
This report covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report provides an overview of the current treatment options, pipeline products in development, as well as current and future R&D trends. Key topics covered include a strategic competitive assessment of current and future drugs, unmet needs, KOL insights, and implications for the Systemic Lupus Erythematosus and Lupus Nephritis market. The base year of the sales forecast model is 2024, and the forecast period...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2026" provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report provides top line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Rheumatoid Arthritis - Global Clinical Trials Review, 2026
Understand the Global Clinical Trials Landscape for Rheumatoid Arthritis Rheumatoid arthritis remains a key focus area in global clinical research, with ongoing trials shaping the future of treatment and innovation. This report provides a comprehensive snapshot of the global clinical trials landscape, covering trial activity across regions, countries (G7 & E7), phases, statuses, endpoints, and sponsor types. As a result, you gain a clear understanding of where research is accelerating and how the competitive landscape is evolving. Report Value Proposition...
-
Sector Analysis
Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2034
Systemic lupus erythematosus (SLE) is the most common form of lupus. It is an autoimmune disease in which the body’s immune system mistakenly attacks its own healthy cells and organs, leading to inflammation and damage (Centers for Disease Control and Prevention, 2024). SLE is a chronic disease that can affect the skin, joints, blood, and organs such as the kidneys, lungs, and heart. There is currently no cure for SLE, but it can be treated. LN is one of the...
-
Product Insights
Psoriasis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Psoriasis - Global Clinical Trials Review, 2025" provides an overview of Psoriasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Systemic Sclerosis (Scleroderma): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2025" provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Thematic Analysis
Genomics: FutureTech Series
Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies. GlobalData’s latest FutureTech Series: Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility. Using GlobalData’s proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world...
-
Product Insights
Lupus Nephritis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2025" provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Pustular Psoriasis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Pustular Psoriasis - Global Clinical Trials Review, 2025" provides an overview of Pustular Psoriasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pustular Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.